thanks
Sunday, March 31, 2024
Thursday, March 28, 2024
DAL: Well oiled machine...
Target price : 55
Watch it climb ..
Friday, March 22, 2024
Price trading strategies
There are 4 main price based strategies - 1) trend following (find a reversal aka new trend, hop on as soon as possible and HODL till it ends),
2) breakout (stalk a consolidation, hop on breakout and exit at 1-2x of the height of consolidation),
3) mean reversion (identify an established trend, define a distance that constitutes stretched too far from the trend average, hop on, exit when price meets the trend),
4) range trading (find an established range, buy in the bottom third, sell in the top third). Everything else is finessing entry/exit and position sizing
Wednesday, March 20, 2024
KeyBanc initiates Overweight rating on Oracle with $150 stock target
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
Tuesday, March 19, 2024
DAL .. DAL .. DAL
https://finance.yahoo.com/news/heres-best-airline-stock-buy-151000911.html
The latest trading session saw Delta Air Lines (DAL) ending at $43.44, denoting a +0.74% adjustment from its last day's close. This change outpaced the S&P 500's 0.63% gain on the day. Meanwhile, the Dow gained 0.2%, and the Nasdaq, a tech-heavy index, added 0.82%.
Sunday, March 17, 2024
Wednesday, March 13, 2024
TSLA :: Average Target Price 211.45
Tesla reaction is overrated and overdone based on FSKR and Cybertruck
The growth rate of the number of Tesla vehicles has been significant over the years. In 2023, Tesla produced 1,845,985 vehicles, marking a 35% increase from the previous year. The company delivered over 484,000 vehicles in the fourth quarter of 2023 alone. Overall, in 2023, Tesla sold 1,808,581 vehicles[3]. Since 2018, Tesla has steadily increased its production numbers, with 254,530 vehicles produced in 2018 and reaching 1,845,985 vehicles in 2023[2]. This growth trajectory showcases Tesla's rapid expansion and increasing market presence.
Citations:
[1] https://www.investing.com/academy/statistics/tesla-facts/
[2] https://tridenstechnology.com/tesla-sales-statistics/
[3] https://ir.tesla.com/press-release/tesla-vehicle-production-deliveries-and-date-financial-results-webcast-fourth-quarter-2023
[4] https://www.statista.com/topics/2086/tesla/
[5] https://backlinko.com/tesla-stats
Monday, March 11, 2024
Vanguard for foundation, GS for Speculation
https://marketsblock.com/stock-upgrades-and-downgrades/
Search for the upgrades by GS (Goldman Sachs)
Best
The Real Software Company, ORCL
Oracle is a company that does due diligence in all its endeavors to bring rigor and perfection in anything it makes whether its Databases, Applications, Middleware, Ad management, you name it.
The due diligence is not limited to these areas but also tangential aspects like Performance, Security, Privacy and more.
THERE are very few companies where all of the following principles are embodies and best practices therein.
A long follower of Oracle and X-Oracle,
Tgt price: 150
Sunday, March 10, 2024
RNA: 40% upside
Thursday, March 7, 2024
JPMC and GS upgrades
Wednesday, March 6, 2024
Monday, March 4, 2024
NVDA: $886.52, 900 ==> 1000
https://www.tipranks.com/news/nvidia-stock-above-800-ivan-feinseth-looks-for-the-next-price-move
The article discusses Nvidia's stock performance, with analyst Ivan Feinseth predicting a rise above $800. Supported by a Strong Buy consensus rating from 37 analysts, the stock is expected to reach $886.52, reflecting an 8% premium in a year. Nvidia's success is attributed to its Data Center segment's revenue surge and collaborations, indicating further growth potential
Sunday, March 3, 2024
Slimgate
### Side Effects of Ozempic
Ozempic (semaglutide) is a medication used to treat type 2 diabetes. Like any medication, it can cause side effects. The most common side effects of Ozempic include:
- Nausea
- Diarrhea
- Stomach (abdominal) pain
- Vomiting
- Constipation[1][2][3]
In addition to these common side effects, there are other potential adverse reactions associated with Ozempic, such as:
- Hypoglycemia (low blood sugar)
- Increased heart rate at rest
- Agitation, irritability, or abnormal behaviors
- Pancreatitis (swelling of the pancreas)
- Gallbladder problems
- Diabetic retinopathy
- Suicidal thoughts or tendencies[2][3]
Less common but more serious side effects may include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks, and bile duct blockage. It is essential to seek medical attention if experiencing severe symptoms like severe vomiting and diarrhea, severe abdominal pain, or jaundice.[5]
Goldman Sachs Action
The Goldman Sachs Group Increases Vertex (NASDAQ:VERX) Price Target to $39.00
Defense WorldRead The Goldman Sachs Group Increases Vertex (NASDAQ:VERX) Price Target to $39.00 at Defense World.Apple removed from Goldman Sachs 'conviction buy list' - Breaking Latest News
Breaking Latest NewsIn February, Cupertino shares lost 1.9%, compared to +5.2% for the benchmark. Goldman confirms Buy on Apple and raises price target. Inclusion or ...Schrödinger (NASDAQ:SDGR) Price Target Cut to $26.00 by Analysts at The Goldman Sachs Group
MarketBeatThe Goldman Sachs Group dropped their price target on Schrödinger from $29.00 to $26.00 and set a "neutral" rating for the company in a research ...The Goldman Sachs Group Boosts National Vision (NASDAQ:EYE) Price Target to $20.00
Defense WorldRead The Goldman Sachs Group Boosts National Vision (NASDAQ:EYE) Price Target to $20.00 at Defense World.The Goldman Sachs Group Trims Denali Therapeutics (NASDAQ:DNLI) Target Price to $50.00
American Banking NewsThe brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group's target price would suggest a potential upside of 139.69% from the ...Okta (NASDAQ:OKTA) Price Target Increased to $120.00 by Analysts at The Goldman Sachs Group
American Banking NewsThe brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group's target price would suggest a potential upside of 10.61% from the ...The Goldman Sachs Group Increases Iovance Biotherapeutics (NASDAQ:IOVA) Price Target ...
American Banking NewsThe firm presently has a “buy” rating on the biotechnology company's stock. The Goldman Sachs Group's target price would indicate a potential upside ...The Goldman Sachs Group Increases Iovance Biotherapeutics (NASDAQ:IOVA) Price Target ...
Defense WorldThe firm currently has a “buy” rating on the biotechnology company's stock. The Goldman Sachs Group's price target points to a potential upside of ...Goldman Sachs Downgrades Estée Lauder Companies (EL) | Nasdaq
NasdaqSee our leaderboard of companies with the largest price target upside. · VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 6,512K ...Apple got snubbed by Goldman Sachs and fell behind Microsoft after a turbulent week
MSNNotably, Goldman Sachs still rates Apple stock as a “buy,” and even raised its price target for the shares from $223 to $232 (much higher than the ...